https://pharmadog.xyz/news/659803 pharmadog en 2026-11-09T18:54:47.000Z Pentagon removes WuXi AppTec from Chinese military companies list, but risk of redesignation remains https://pharmadog.xyz/news/659804 pharmadog en 2026-11-09T18:54:19.000Z Third Rock Ventures commits up to $2.16 billion to AI-driven Chinese biotech Funnel Biosciences https://pharmadog.xyz/news/659827 pharmadog en 2026-11-09T18:47:04.000Z FDA mandates label update for all GLP-1 drugs to warn of rare eye disease risk https://pharmadog.xyz/news/659828 pharmadog en 2026-11-09T18:33:07.000Z Phase 3 trial shows Zealand-Boehringer obesity drug survodutide does not raise cardiovascular death risk https://pharmadog.xyz/news/659829 pharmadog en 2026-11-09T18:21:52.000Z Lilly's oral GLP-1 Foundayo cuts sleep apnea severity in Phase 3, paving way for second FDA filing https://pharmadog.xyz/news/659679 pharmadog en 2026-11-09T17:54:13.000Z Democrats’ Midterm Wins Boost Hospital Prospects as CVS Breakup Looms https://pharmadog.xyz/news/659659 pharmadog en 2026-11-09T17:26:05.000Z Vir Biotechnology reports 44% undetectable hepatitis delta virus in Phase 3 trial, eyes mid-2027 filing https://pharmadog.xyz/news/659511 pharmadog en 2026-11-09T16:53:21.000Z American Heart Association meeting reports neutral outcomes for inflammation and Lp(a) trials https://pharmadog.xyz/news/659531 pharmadog en 2026-11-09T16:27:00.000Z Argenx to acquire Unnatural Products' macrocyclic peptide platform for $550 million upfront https://pharmadog.xyz/news/659467 pharmadog en 2026-11-09T16:13:22.000Z Heron sells assets to CorMedix for $145M upfront, Faeth shares plunge https://pharmadog.xyz/news/659468 pharmadog en 2026-11-09T16:01:05.000Z Delix Therapeutics secures $100 million Series C to advance psychedelic pipeline https://pharmadog.xyz/news/659299 pharmadog en 2026-11-09T15:58:37.000Z Boehringer Ingelheim to seek approval for obesity injection survodutide after trial shows no added cardiovascular risk https://pharmadog.xyz/news/659343 pharmadog en 2026-11-09T15:56:55.000Z FDA warns GLP-1 weight-loss drugs may cause rare eye stroke condition https://pharmadog.xyz/news/632799 pharmadog en 2026-11-09T15:51:00.000Z Compass Pathways to file FDA approval for psilocybin depression therapy within weeks https://pharmadog.xyz/news/659324 pharmadog en 2026-11-09T15:46:02.000Z J&J/Protagonist’s oral Icotyde shows Phase 3 benefit in psoriatic arthritis but trails AbbVie’s Skyrizi https://pharmadog.xyz/news/659363 pharmadog en 2026-11-09T15:37:00.000Z Biotech controversies cloud Vivek Ramaswamy’s Ohio governor campaign https://pharmadog.xyz/news/659325 pharmadog en 2026-11-09T15:34:40.000Z Novartis' Phase 3 HORIZON trial shows pelacarsen lowers Lp(a) but fails to cut cardiovascular events https://pharmadog.xyz/news/659326 pharmadog en 2026-11-09T15:24:00.000Z Argenx to acquire peptide specialist Unnatural Products in deal worth up to $1.15 billion https://pharmadog.xyz/news/659175 pharmadog en 2026-11-09T14:36:12.000Z New evidence links gene‑therapy viral vectors to tumor formation in pediatric patients https://pharmadog.xyz/news/659131 pharmadog en 2026-11-09T14:30:34.000Z Eli Lilly to pursue FDA approval for obesity drug in obstructive sleep apnea after positive Phase 3 trial https://pharmadog.xyz/news/659176 pharmadog en 2026-11-09T14:30:00.000Z Lilly's oral GLP-1 pill Foundayo reduces sleep apnea events in late-stage trials https://pharmadog.xyz/news/134233 pharmadog en 2026-11-09T14:21:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/659157 pharmadog en 2026-11-09T14:12:08.000Z Novo’s IL-6 inhibitor ziltivekimab may target milder cardio-renal patients after Phase 3 miss https://pharmadog.xyz/news/659132 pharmadog en 2026-11-09T14:00:44.000Z Marea Therapeutics' triglyceride drug lowers levels without raising blood sugar in high-risk patients https://pharmadog.xyz/news/658963 pharmadog en 2026-11-09T13:44:28.000Z Zura Bio’s Phase 2 trial of tibulizumab fails, shares plunge https://pharmadog.xyz/news/658839 pharmadog en 2026-11-09T12:55:07.000Z Trump administration issues new guidelines to curb AI-driven bioweapon threats https://pharmadog.xyz/news/658627 pharmadog en 2026-11-09T11:23:25.000Z Argenx to acquire macrocycle biotech Unnatural Products in up to $1.15 billion deal https://pharmadog.xyz/news/658417 pharmadog en 2026-11-09T10:00:00.000Z Early technical expertise key to tackling complex life-science construction projects https://pharmadog.xyz/news/658415 pharmadog en 2026-11-09T10:00:00.000Z State incentives can shape site decisions for commercial-stage life sciences firms https://pharmadog.xyz/news/658416 pharmadog en 2026-11-09T10:00:00.000Z Phase II success does not guarantee easy Phase III launch, says Thermo Fisher https://pharmadog.xyz/news/658229 pharmadog en 2026-11-09T09:30:00.000Z Democrats weigh limits of health-care reforms after midterm win https://pharmadog.xyz/news/658230 pharmadog en 2026-11-09T09:30:00.000Z AI chatbots may help men share emotions, study suggests https://pharmadog.xyz/news/658228 pharmadog en 2026-11-09T09:30:00.000Z Global liver experts agree on definition of acute-on-chronic liver failure https://pharmadog.xyz/news/658227 pharmadog en 2026-11-09T09:30:00.000Z CVS split into two entities fails to address core issues in pharmacy benefit management https://pharmadog.xyz/news/659108 pharmadog en 2026-11-09T09:21:00.000Z Zura Bio halts hidradenitis suppurativa program after tibulizumab fails phase 2 trial https://pharmadog.xyz/news/659274 pharmadog en 2026-11-09T09:20:00.000Z Delix Therapeutics raises $100M Series C to advance non-hallucinatory psychedelic for depression https://pharmadog.xyz/news/659109 pharmadog en 2026-11-09T09:06:00.000Z Windward Bio targets $204M Nasdaq IPO to fund Chinese respiratory drug program https://pharmadog.xyz/news/659107 pharmadog en 2026-11-09T08:57:00.000Z Spruce Biosciences spins out preclinical endocrinology program into new unit Adrenyx, backed by up to $50 million https://pharmadog.xyz/news/658941 pharmadog en 2026-11-09T07:30:00.000Z Kyorin signs $140M deal for Japan rights to Edesa's ARDS antibody https://pharmadog.xyz/news/657535 pharmadog en 2026-11-09T05:08:00.000Z AbbVie and BMS each secure FDA approval, but impact of their neuro‑drug acquisitions remains uncertain https://pharmadog.xyz/news/657536 pharmadog en 2026-11-09T05:02:00.000Z FDA launches Rare Disease Framework to embed patient input early in drug development https://pharmadog.xyz/news/657537 pharmadog en 2026-11-09T05:01:00.000Z Gene therapy sponsors urged to address six GMP manufacturing considerations early https://pharmadog.xyz/news/659739 pharmadog en 2026-11-09T05:00:00.000Z Abiomed issues recall of Automated Impella Controllers due to safety risk https://pharmadog.xyz/news/659740 pharmadog en 2026-11-09T05:00:00.000Z FDA orders label warnings for GLP-1 drugs over rare eye-loss risk https://pharmadog.xyz/news/658602 pharmadog en 2026-11-09T04:56:00.000Z Vir Biotechnology's Phase 3 Trial Shows Primary Endpoint Success in Chronic Hepatitis Delta https://pharmadog.xyz/news/658158 pharmadog en 2026-11-09T04:12:00.000Z Valneva's Shigella vaccine cuts infection rates in phase 2 trial https://pharmadog.xyz/news/658159 pharmadog en 2026-11-09T03:19:00.000Z Argenx acquires Unnatural Products for up to $1.15 billion to boost oral peptide platform https://pharmadog.xyz/news/656331 pharmadog en 2026-11-08T22:15:00.000Z Study finds training bystanders and responders does not boost survival after sudden cardiac arrest https://pharmadog.xyz/news/655971 pharmadog en 2026-11-08T21:15:33.000Z Vir Biotechnology reports positive results for hepatitis D combo in first pivotal trial https://pharmadog.xyz/news/653843 pharmadog en 2026-11-08T09:30:00.000Z Recent heart-drug trials miss endpoints, raising doubts about AI-driven drug design https://pharmadog.xyz/news/658918 pharmadog en 2026-11-08T05:00:00.000Z Fresh & Ready Foods recalls 2,414 Fresh To You sausage, egg & cheese biscuit sandwiches over possible Listeria contamination https://pharmadog.xyz/news/651503 pharmadog en 2026-11-07T21:39:02.000Z New studies highlight hurdles in lowering blood pressure after stroke or in diabetes patients https://pharmadog.xyz/news/651459 pharmadog en 2026-11-07T21:12:08.000Z FDA opens investigation into Novartis' Zolgensma after cancer cases reported